Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial
Almandoz J, Miras A, Blüher M, Orozco Del Pino P, Mojdami D, Batterham R, Trice K, Goebel B, Tangi F
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- pmc:PMC13697276
- Published
- Oct 14, 2026
- Venue
- Obesity pillars
- PMC
- PMC13697276
- License
- CC-BY
- Provenance
- europepmc